“a decreasing trend”

Prevalence and trend of TTIs in blood donors according to donor status The analysis of first-time donors (who comprised 23.3% of all donors) showed a decreasing trend in the prevalence of HBV ( P < 0.0001, R: -0.98), HIV ( P < 0.18, R: -0.49), HCV ( P < 0.0001, R: − 0.98) and HTLV 1/2 ( P < 0.0001, R: − 0.95) from 2010 to 2018.

The post hoc analysis indicated a decreasing trend for latency across trials [ Figure 4D , 4 weeks: F trial (4,44) = 162.503, P < 0.0001; 12 weeks: F trial (4,44) = 141.706, P < 0.0001; 24 weeks: F trial (4,44) = 180.477, P < 0.0001].

Overall, 12.5% of treated hypertensive patients received two or more BP lowering medications, with a decreasing trend from wealthier to poorer countries (HIC, 18.1%, UMIC 14.5%, LMIC 14.1%, LIC 1.6%; P < 0.0001).

Urinary pathogens showed a decreasing trend for nitrofurantoin (from 17% to 7%, p=0.0001).

Private insurance, including health maintenance organizations (HMOs), were the largest payers for this procedure; however, a decreasing trend in DCE covered by private insurance was noticed (50.2% to 47.3%; P < 0.0001).

The inhibitory effect of anti-rTsSPc antibody was antibody dose-dependent ( r = 0.967, P < 0.01), and exhibited a decreasing trend with increasing of serum dilution ( F = 1797.671, P < 0.0001) ( Fig 16E ).

Statistical analysis of the data performed in the three groups confirmed the presence of a decreasing trend over time in this difference in the CF group (p<0.0001) and the increasing trend in the non-CF (p<0.0001) and in the HTZ (p = 0.04) groups.

The suppression was dose dependent for anti-rTsSerp antibodies ( r = 0.986) and showed a decreasing trend with increasing serum dilutions ( F = 181.170, P < 0.0001) (Figure 10 F).

Kinesiophobia, as measured by the Tampa Scale score, demonstrated a decreasing trend with a significant difference ( P < 0.0001*).

Further we have observed a decreasing trend in the level of Tregs in children born to both infected and uninfected mother as compared to the cord blood (p <0.0001 for CFA+ve and p < 0.0001 for CFA-ve).

Pairwise reduction curves showed a decreasing trend on transitioning from Serotype I to II ( P < 0.0001) in 34/48 (70.8%) samples, from Serotype I to III ( P = 0.0281) in 30/48 (62.5%) samples, and from Serotype I to IV ( P < 0.0001) in 38/48 (79.2%) samples ( Figure 5 (C)).

Joinpoint regression analysis also showed a decreasing trend in prevalence according to patient age (APC = -16.2; p<0.0001) ( Supplementary Figure S1 ).

In contrast, a decreasing trend in FCR ( p < 0.0001) was observed in Cobb 500, Ross 308, and Ross strains when fed P- and Ca-deficient basal diet supplemented with phytase.

acute hypoxemic respiratory failure assisted mechanical ventilation biomarker diaphragm diaphragmatic ultrasound skeletal troponin weaning A decreasing trend over time was also detected for myoglobin ( p < 0.0001), with a 45% decrease from Day 1 to Day 2 and almost a 30% decrease from Day 2 to Day 3.

The incidence rate showed a rapidly increasing trend from 1975 to 1987, with an APC of 3.3% (95% confidence interval [CI] = 2.8–3.9%, P < 0.0001), while this increase slowed from 1988 to 2001 (APC = 0.8%, 95% CI = 0.4–1.1%, P < 0.0001), and was followed by a decreasing trend from 2002 to 2016 (APC= −0.7%, 95% CI= −0.9% to −0.5%, P < 0.0001).

Also, VAS scores had a decreasing trend between the first and second treatment sessions as the mean patient VAS score fell from 10±0.04 to 5.53±2.41 ( P <0.0001).

Tests of the year main effect revealed a decreasing trend for wrist ( p <.0001), an increasing trend for vertebral ( p =.0012), and no statistically significant change for humerus ( p =.2226).

The mean QoL domains scores showed a decreasing trend with increasing motor dysfunction of the child, with a statistical association for physical ( r = −0.327, P < 0.0001) and psychological domains ( r = −0.440, P < 0.0001).

The probability of saccades occurring within the 200–300 ms window showed an initial increase followed by a decreasing trend, with significant differences between easy and hard tasks (Fig. 7a , t 43 = 5.818, p < 0.0001, d = 1.774).

25.22 ± 3.58 kg) exhibited the same trend as BF and increased progressively across the BMI categories ( p < 0.0001), LM% revealed a decreasing trend, with normal-weight older adult males demonstrating the highest LM% (71.06 ± 6.73%), followed by overweight (64.35 ± 4.82%) then obese (59.66 ± 4.07%) ( p < 0.0001) individuals.

IHM rates also varied between regions, increasing in all but the southeast, which showed a decreasing trend (y = -0.1122x + 4.427; R 2 = 0,728; P < 0.0001).

Our observations unveiled a clear correlation between the accumulation of TIGIT + Foxp3 + Tregs and the growth of ovarian cancer tumors (r 2 = 0.9258, p < 0.0001), while the levels of TIGIT − Foxp3 + Tregs displayed a decreasing trend in parallel (r 2 = 0.9258, p < 0.0001) (see Fig. 3 A).

However, as the clinical stage advanced, both the SDNN and RMSSD displayed a decreasing trend ( P < 0.0001).

The main effect of time was significant and there was a decreasing trend in LEDD (estimate = − 48.8, SE = 8.4, p < 0.0001).

In the total population, no significant trend could be observed in the T2DM group [APC: −0.50% (−1.12–0.10%), p = 0.0991], while a decreasing trend was found in the Non-Diab group [APC: −1.79% (−2.07–−1.52%), p < 0.0001].